Business Description
Bolt Biotherapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US0977021049
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.9 | |||||
Equity-to-Asset | 0.69 | |||||
Debt-to-Equity | 0.22 | |||||
Debt-to-EBITDA | -0.26 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -5.18 | |||||
Beneish M-Score | -2.05 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 209.7 | |||||
3-Year EBITDA Growth Rate | -8.8 | |||||
3-Year EPS without NRI Growth Rate | -6 | |||||
3-Year FCF Growth Rate | -5.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 15.48 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.41 | |||||
9-Day RSI | 47.92 | |||||
14-Day RSI | 49.39 | |||||
6-1 Month Momentum % | -41.36 | |||||
12-1 Month Momentum % | -33.88 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.28 | |||||
Quick Ratio | 4.28 | |||||
Cash Ratio | 4.12 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.2 | |||||
Shareholder Yield % | 9.94 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -663.38 | |||||
Net Margin % | -592.57 | |||||
FCF Margin % | -573.87 | |||||
ROE % | -57.72 | |||||
ROA % | -41.72 | |||||
ROIC % | -122.26 | |||||
3-Year ROIIC % | -71.45 | |||||
ROC (Joel Greenblatt) % | -308.8 | |||||
ROCE % | -52.8 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.2 | |||||
PB Ratio | 0.29 | |||||
Price-to-Tangible-Book | 0.29 | |||||
EV-to-EBIT | 0.41 | |||||
EV-to-EBITDA | 0.42 | |||||
EV-to-Revenue | -2.69 | |||||
EV-to-FCF | 0.47 | |||||
Price-to-Net-Current-Asset-Value | 0.65 | |||||
Price-to-Net-Cash | 0.71 | |||||
Earnings Yield (Greenblatt) % | 243.9 | |||||
FCF Yield % | -258.74 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BOLT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Bolt Biotherapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 11.166 | ||
EPS (TTM) ($) | -1.74 | ||
Beta | 0.76 | ||
Volatility % | 61.27 | ||
14-Day RSI | 49.39 | ||
14-Day ATR ($) | 0.038389 | ||
20-Day SMA ($) | 0.64783 | ||
12-1 Month Momentum % | -33.88 | ||
52-Week Range ($) | 0.545 - 1.56 | ||
Shares Outstanding (Mil) | 38.26 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Bolt Biotherapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Bolt Biotherapeutics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Bolt Biotherapeutics Inc Frequently Asked Questions
What is Bolt Biotherapeutics Inc(BOLT)'s stock price today?
When is next earnings date of Bolt Biotherapeutics Inc(BOLT)?
Does Bolt Biotherapeutics Inc(BOLT) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |